Common Variants in the Adiponectin Gene (ADIPOQ) Associated With Plasma Adiponectin Levels, Type 2 Diabetes, and Diabetes-Related Quantitative Traits
Open Access
- 1 December 2008
- journal article
- research article
- Published by American Diabetes Association in Diabetes
- Vol. 57 (12) , 3353-3359
Abstract
OBJECTIVE— Variants in ADIPOQ have been inconsistently associated with adiponectin levels or diabetes. Using comprehensive linkage disequilibrium mapping, we genotyped single nucleotide polymorphisms (SNPs) in ADIPOQ to evaluate the association of common variants with adiponectin levels and risk of diabetes. RESEARCH DESIGN AND METHODS— Participants in the Framingham Offspring Study (n = 2,543, 53% women) were measured for glycemic phenotypes and incident diabetes over 28 years of follow-up; adiponectin levels were quantified at exam 7. We genotyped 22 tag SNPs that captured common (minor allele frequency >0.05) variation at r2 > 0.8 across ADIPOQ plus 20 kb 5′ and 10 kb 3′ of the gene. We used linear mixed effects models to test additive associations of each SNP with adiponectin levels and glycemic phenotypes. Hazard ratios (HRs) for incident diabetes were estimated using an adjusted Cox proportional hazards model. RESULTS— Two promoter SNPs in strong linkage disequilibrium with each other (r2 = 0.80) were associated with adiponectin levels (rs17300539; Pnominal [Pn] = 2.6 × 10−8; Pempiric [Pe] = 0.0005 and rs822387; Pn = 3.8 × 10−5; Pe = 0.001). A 3′-untranslated region (3′UTR) SNP (rs6773957) was associated with adiponectin levels (Pn = 4.4 × 10−4; Pe = 0.005). A nonsynonymous coding SNP (rs17366743, Y111H) was confirmed to be associated with diabetes incidence (HR 1.94 [95% CI 1.16–3.25] for the minor C allele; Pn = 0.01) and with higher mean fasting glucose over 28 years of follow-up (Pn = 0.0004; Pe = 0.004). No other significant associations were found with other adiposity and metabolic phenotypes. CONCLUSIONS— Adiponectin levels are associated with SNPs in two different regulatory regions (5′ promoter and 3′UTR), whereas diabetes incidence and time-averaged fasting glucose are associated with a missense SNP of ADIPOQ.Keywords
This publication has 24 references indexed in Scilit:
- The genetic susceptibility to type 2 diabetes may be modulated by obesity status: implications for association studiesBMC Medical Genetics, 2008
- Genetic Influences of Adiponectin on Insulin Resistance, Type 2 Diabetes, and Cardiovascular DiseaseDiabetes, 2007
- Comparison of anthropometric, area- and volume-based assessment of abdominal subcutaneous and visceral adipose tissue volumes using multi-detector computed tomographyInternational Journal of Obesity, 2006
- Measurement of the High–Molecular Weight Form of Adiponectin in Plasma Is Useful for the Prediction of Insulin Resistance and Metabolic SyndromeDiabetes Care, 2006
- Adipose TissueDiabetes, 2006
- Impaired Multimerization of Human Adiponectin Mutants Associated with DiabetesJournal of Biological Chemistry, 2003
- Penalized Survival Models and FrailtyJournal of Computational and Graphical Statistics, 2003
- Genomewide Search for Type 2 Diabetes–Susceptibility Genes in French Whites: Evidence for a Novel Susceptibility Locus for Early-Onset Diabetes on Chromosome 3q27-qter and Independent Replication of a Type 2–Diabetes Locus on Chromosome 1q21–q24The American Journal of Human Genetics, 2000
- Multipoint Quantitative-Trait Linkage Analysis in General PedigreesThe American Journal of Human Genetics, 1998
- Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in manDiabetologia, 1985